Question · asked by 1 review

Oxcarbazepine vs phenytoin: Time to treatment failure (any reason related to treatment) All participants Range of

Summary of findings: oxcarbazepine showed no clear difference in time to treatment failure (any reason related to treatment) All… compared with phenytoin (primary outcomes) (moderate certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Summary of findings: oxcarbazepine vs phenytoin (primary outcomes)
Time to treatment failure (any reason related to treatment) All participants Range of · adults and children with newly diagnosed epilepsy
Summary of findings: oxcarbazepine showed no clear difference in time to treatment failure (any reason related to treatment) All… compared with phenytoin (primary outcomes) (moderate certainty).
Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review (2018) · Cochrane Headline outcomes only
HR 0.78 [0.53, 1.14]2 studies · 476 participantsModerate

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
2018 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.